Simple Blood Test Could Transform Acute Leukemia Diagnosis

Researchers have identified tiny RNA molecules in blood serum that could serve as non-invasive markers for acute myeloid leukemia (AML). If validated, the finding could enable earlier detection and monitoring without bone marrow biopsies, potentially reducing costs and improving patient outcomes in a disease where timing is critical.

Originaltitel: The potential role of serum extracellular vesicle derived small RNAs in AML research as non-invasive biomarker